O1C O1C11 O1C12 O1C13 O1C14 O1C15 O1C16 O1C ,2 1, O1C O1C1

IBS - 2 -

27 3 6 14:00 16:00 3 302-1 - IBS - 2 - 1. 2. 26 3. - 3 - 4. 4-1 26 1 1 5 1 2 4 2 40 3-4 - 4-2 2 3 2 6 2 5 3 6 2 2 H25.2 2,520 H26.2 2,540 2,960 400 2 2 3 5 5 25-5 - 4-3 4 60-6 - IC 1 PR - 7 - 4 3-8 - OD

服用者向け_資料28_0623

1 2 3 1. 2. 4 3. 4. 1. 5 2. 3. 4. 5. 6 6. 7. 8. 7 9. 10. 11. 8 12. 9 10 11 12 Q-1 : OC Q-2 : OC Q-3 : 21 OC 28 OC 13 Q-4 : OC Q-5 : OC Q-6 : OC 14 Q-7 : Q-8 : OC Q-9 : OC Q-10 : OC Q-11 : OC 15 Q-12 :

2

1 2 17 1884 2 131 1 1..He lived to serve 2 2 2 2 14,416 104,000 1 QOL Quality of Life 2 21 2013 25 21 3 4 5 QOL 6 QOL QOL 59 1 60 7 QOL QOL 8 2,774 2015 27 5 7 241 2015 27 5 8 12 2015 3 7 58 1,030 113

VISPO /表1-4

7 2005 1,132 5,249 362 13,666 311,809 1,359 3,723 1,669 538 3,737 17,418 39,036 75,694 5,281 1,169 161,502 7,463 11,408,436 500,000 13,263 192,052 41,391 49,706 136,232 61,102 12,402,182 11,573,898 273,042

PSCHG000.PS

2015電磁波＿歯科医.rtfd

194621 22 50.06 53.96 90.00 28 87.14 85.00 80.00 75.00 70.00 22 53.96 28 80.75 65.00 60.00 55.00 22 50.06 50.00 Quality of Life !! 281026 281026 -6,500-5,500-4,500-3,500-2,500-1,500-500 500 1,500 2,500-6,401-1,281-3,565-2,154-2,265-2,027-1,869-1,657

『こみの株式会社』の実践

2003 . JA JA A JA 811 2005/8/11 1003 452 10 960 28 2005/8/11 1003 452 6 120 29 2005/8/11 2003 151 10 420 33 2005/8/11 2003 211 3 180 31 2005/8/11 2003 211 3 150 32 827 400 5 80 221 2005/6/25 900 3 300

15 7 26 1,276 3,800 1 16 15 1 2 3 4 2

1 15 7 26 1,276 3,800 1 16 15 1 2 3 4 2 JA 3 4 2 1 3 2001 1981 6 10% 10 30% 1 2 JA JA 2 4 JA 2 1 2 1 2 1 2 1 2 1 2 7 5 1 1 1 3 1 6 1 1 2 2 1 7 2 3 3 53 1 2000 30 8 250 53 435 20 35 3 1 8 2 4 3 2 2 232

EX-word_Library_JA

JA 2 3 4 5 14 7 1 2 6 3 1 2 7 3 8 27 1 2 3 1 2 3 9 1 2 3 1 2 3 10 12 13 14 11 1 12 1 2 13 1 2 3 25 14 1 2 3 25 15 1 2 3 25 16 1 2 3 25 17 1 2 3 25 18 1 2 3 4 25 19 1 2 3 4 25 20 1 2 21 3 4 25 22 1 2 3

324.pdf

50 50 10 30 11 26 12 27 14 16 27 18 20 21 22 22 22 22 23 24 24 1 No.324 JA 2 85 69 20 12 81 18 12 22 93 10 31 3 50 50 30 30 50 22 27 27 10 16 14 52 10 62 15 64 25 24 50 4 25 23 27 5 10 11 25 6 11 49 10

LUCUA1100＆LUCUA 1周年アニバーサリー！ ～ルクア大阪が発信する新プロジェクト「LIFE」についてのご案内～

2

1 2 3 1) 2) 3) 2 3 1 2 3 4 5 6 7 8 9 10 11 4 12 13 14 15 X 16 X 17 X CT 18 MRI 19 20 4 A. ENG T&T B. ABLB SISI ABR ASSRMLRSRL 5 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 1 2 3 4 7 1 POS( Problem

A B C A B A S11 S12 S13 16

54 6 27 11101210A 6 26 13401440B 6 26 13401440C 6 27 13201420A 6 27 13201420B 6 26 9301130A S11 S12 S13 16 S14 6 26 9301130B L S21 S22 S23 S24 6 26 9301130C S31 S32 S33 S34 S35 17 6 26 14501650A S41 S42

- 1 - 15 2030 4 21 21-2 - 2 1 21 21 4 22 31 10 5 26 ( JA ) - 3 - 4 21 7 9 9 34 1,386 1,003 94 58 1,155 60 25 33 1 3 2-4 - 12 17 60 7 7 12 H1217 4 7 30 34 19-5 - - 6 - (BMI*18.5) 20 15.2%30 8.% 20 86.4%30

障害者職域拡大カリキュラム研究会中間報告書構成案

3 4 5 5 7 7 9 () 9 ()23 34 1 36 47 49 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ADL QOL 36 37 38 39 40 41 42 43 44 45 46 16 8 () 19 ( ) () 21 () 47 16

,

untitled

[ a] [ ] ( 15) 2005( 17) 2006( 18) [ ( )] [ b] 1996( 8) 1998( 10) 2003( 15) 2006( 18) [ c] [ ] 24

[ a ( :2-4)] [ ( :2-4)] [ ( :2-4)] 1955( 30) 1972( 47) 10 1974( 49) 10 1985() 1996( 8) [ ( :2-4)] 1998( 10) 1992( 4) 2001( 13) 1996( 8) 2000( 12) 23 [ a] [ ] 1993 5 12 3 2003( 15) 2005( 17) 2006( 18) [

untitled

5 1.() 2.() 3.(JA ) 2 3 4 5 6 7 8 9 10 11 12 13 1,000m 165.52km2 1,200-1- H15.8.1 1,163 2,121 278 H19.2.1 60 12 8 15 13 4 10 14 4 13 15 16 22 16 12 21 44 81-2- - 0 - - 1 - - 2 - - 3 - - 4 -

untitled

230 1985 17 2002 2006 8 2007 9 2010 3 1 2 6,000 3 2007 9 2008 7 2009 7 10 2008 7 2009 7 2009 10 1 2004 4 6 3 2005 77 Medical polis 4 21 2006 3 2004 9 15 2004 2005 2006 2 4 3 1 2 1 60 8 108 100 100 1 100

untitled

1993 2 2.1 2 1 200235 1992 6 7 3 3 84 JA 1990 47.3% 46.5% 1990 31.7% 56.9% 37 6 4 1976 2.2 2.2 1976 1974 1976 1981 1 3.5 1985 60 2005 2006 2006 27 103 522 284 3.5 3.6 2003 109 59.6% 54.1% 31.2% 1970

part 2 in 2 2 1 1 3

untitled

1

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70

16 23 270 5 1 2 3 1 2 3 1 2 3 6 5 54 44 9 9 4,000 118 7 5 JA 8 1 1 2 16 48,000 1 1 1 1 2 2 3 1, 312. 87 4 5 10 3 31 6 10 4 25 7 3 1 2 8 2 495. 84 1 296. 49 2 199. 35 1 124. 62 54. 50 28. 80 34. 17 54.

- 2 -

- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - A) B) C) D) E) F) - 10 - G) H) I) J) P - 11 - 001 1,416,0003/4 1,062,000 002 100,000 50,00023 1,150,000 2,100,000 200,000+ 100,0000.9 1,600,000 JA

11 10 712 12 10 21 21 1024 Division of Public Health) ()()( )(Ph.D) 21

11 10 712 12 10 21 21 1024 Division of Public Health) ()()( )(Ph.D) 21 1 218 2 3 113 218 13 33039 388 29164 30 4929 28 16 413 16 13 5 24 6 1 2 121317 3 1 2 3 4 () () 30,000 (120235) 430() 1 245 3 11121317

1

untitled

講演 A TMDU) 講演 A 鉞 講演 A SONIC 講演 A 国際セ ョン I 国際セ ョン 1Mongoliathe Land of the Bl

58 会長講演 6 16 14001450A 講演 1 6 16 9301020A BioPsychoSocial Model 講演 2 6 16 10301120A 講演 3 6 16 15001550A 講演 4 6 16 16001650A 講演 5 6 16 17001750A 講演 6 6 17 10001050A 18 講演 7 6 17 11001150A TMDU) 講演 8 6 17

2 3 1 1-2 -

- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - 6 Qol Quality of Life - 22 - - 23 - - 24 - 7 8 9-25 - 10 Forest

BMI BMI

() () 2 QOL () () QOL 11 6 14 20 13.9 20 BMI 12 70 40 11 6 14 20 13.9 20 BMI 12 70 40 57.1 100 ) 1 100 1 250 11 11 430 315 73.3 494 247 50.0 322 60 18.6 12 70 62 88.6 100 18 57.1 1 100 1 250 430 315 73.3

ABS STEP O/D OFF ABS 1 2 3 4 5 6 7 8 3 4 1 2 1 2 3 4 5 6 14 15 7

ABS STEP O/D OFF ABS 1 2 3 4 5 6 7 8 4 5 1 2 3 1

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,

1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20

証明のための準備

証明のための準備 [ 命題 1] 点 O を中心とし 半径が 1 の円周上に3 点 A B C があるとする 点 B C から直線 OA に下ろした垂線の足をそれぞれ D E とする D E が線分 OA 上にあり OE OD 1が成り立つとき が成り立つ C B O E D A G H F ( 証明 ) 直線 OA に関して点 B と対称な点を F とする 直線 OF に点 B D から下ろした垂線の足を

子ども･子育て支援新制度 全国総合システム（仮称）に関するインターフェース仕様書 市町村・都道府県編（初版）

1...1 1.1... 1 1.1.1... 1 1.2... 3 1.2.1... 3 1.2.2... 4 1.3... 5 1.4... 6 1.4.1... 6 (1) B11:...6 (2) B11:...8 1.4.2... 11 (1) B31:... 11 1.4.3... 12 (1) B21, B41:... 12 2... 14 2.1... 14 2.1.1... 14

, ,279 w

No.482 DEC. 200315 14 1754,406 100.0 2160,279 w 100 90 80 70 60 50 40 30 20 10 28.9 23.8 25.0 19.3 30.4 25.0 29.5 80.7 75.0 75.0 70.5 71.1 69.6 76.2 7 8 9 10 11 12 13 23.2 76.8 14 14 1751,189 100.0 2156,574

G

1965

10 12 13 16 17 26 26 31 32 33 33 35 37 38 39 42 43 44 2 15 5 15 57 17 16 4 16 4 2 JA 16 7 1 10 22 11 9 12 6 12 2 12 24 17 1 6 JA 3 4 5 16 7 1 6 ( ) ( ) 15 ( ) ( ) ( ) ( ) ( ) 16 3 35 37 1 93 223 ( ) 218

電話相談「せきずい110番」実施報告書

110 12 2001 1 31 I. 2000 9 17 11 19 126 10 1 8 10 60 41 E - 1 - II. 9/17 9/24 10/1 10/8 10/15 10/22 10/29 11/5 11/12 11/19 19 10 11 9 5 6 10 10 9 6 95 19 20 30 40 50 60 70 (%) 7.7 11.5 15.4 5.8 19.2 21.2

7/30 40 8/4 7/30 18:00 19:00 7/31 10:00 15:00 7/31 10:00 15:00 8/20 12:30 15:00 8/21 13:00 15:00 ( 49ha) JA () TEL 079-421-9026

( ) ( ) 7/30 40 8/4 7/30 18:00 19:00 7/31 10:00 15:00 7/31 10:00 15:00 8/20 12:30 15:00 8/21 13:00 15:00 ( 49ha) JA () TEL 079-421-9026 H144 H2358 H148 H2319 H1563 H23221 H1587 H23122 H1549 5,800 H22265

05-筋・骨格系

LIFE IS 1 eiji asuda MY New Company Profile

7 9 10 11 13 15 16 1 5 6 17 18 19 21 22 LIFE IS 1 eiji asuda MY New Company Profile 2 3 Q1 A 26440 3094,868 2,110 26440 3094,868 2,110 4 A A A A Q2 Q3 Q4 Q5 5 6 QUALITY OF LIFE 7 A + 899 5,895 899 5,895

untitled

JAてんどう391号_0407.indd

終末期癌患者に対する 輸液治療の是非

3 A B NSAID D Case stories A B NSAID D Case stories A. IASP Task Force on Taxonomy WHO Collaborating Center for Palliative Cancer Care : Looking forward to cancer pain relief for all. CBC Oxford, Oxford,

さくらの個別指導 ( さくら教育研究所 ) A AB A B A B A AB AB AB B

1 1.1 1.1.1 1 1 1 1 a a a a C a a = = CD CD a a a a a a = a = = D 1.1 CD D= C = DC C D 1.1 (1) 1 3 4 5 8 7 () 6 (3) 1.1. 3 1.1. a = C = C C C a a + a + + C = a C 1. a a + (1) () (3) b a a a b CD D = D

62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC -

1 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] g/dl A 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - [ ] Point ~ 62 [ ] [ ] [ ] [ ] [ ] [ ] / /

あけぼの231　1-12

プリント

‡ç‡¢‡Ó‡Ü‡Á‡Õ04-08„”

100号表紙

......1201-P1.`5

2009. No356 2/ 5 6 a b b 7 d d 6 ca b dd a c b b d d c c a c b - a b G A bb - c a - d b c b c c d b F F G & 7 B C C E D B C F C B E B a ca b b c c d d c c d b c c d b c c d b d d d d - d d d b b c c b

1 12 ( )150 ( ( ) ) x M x 0 1 M 2 5x 2 + 4x + 3 x 2 1 M x M 2 1 M x (x + 1) 2 (1) x 2 + x + 1 M (2) 1 3 M (3) x 4 +

( )5 ( ( ) ) 4 6 7 9 M M 5 + 4 + M + M M + ( + ) () + + M () M () 4 + + M a b y = a + b a > () a b () y V a () V a b V n f() = n k= k k () < f() = log( ) t dt log () n+ (i) dt t (n + ) (ii) < t dt n+ n

I. はじめに ) Body Mass Index 2012 BMI stage 1 Isometric Knee 2) Extension Force; IKEF 6 6-Minute 3) Walk Distance; 6MWD Quality

30 6 867 872 2015 原著 Characteristics of Fatigue of Gastrointestinal Cancer Patients in the Perioperative Period 1,2) 1) 1,3) 2) EISUKE KOGURE, RPT 1,2), TSUYOSHI HARA, RPT, PhD 1), TAKAYA ISHII, RPT 1,3),

Microsoft Word - Ｈ22年度雄勝中央病院卒後臨床研修プログラム.docx

3 2 380 32 1 202,812 11,967 17.2 1,441 129 24 1 6 1 3 1 2 3 50-60 /2 2 2 1-2 2 1 2 2 1 1-2 1 CPC / 4 / / 2 / AED ICLS JPTEC 3 a: b: c: d: 4 c,d a b d 70% 2 10 4 11 12 21 7 21 8 5 Evidence Based Medicine

タイムテーブル見本集2

900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900 2000 1 2 3 4 5 6 7 8 9 A B C 2012224 1 9001130 14101640 12101310 12101310 12101310 12101310 12101310 12101310 12101310 17201820 17201820 17201820 17201820

107号_表紙_表示用

本文／一般演題＿吉田

184 quality of lifeqol mmhg Hb gdl CA Uml Niveau Hb Hb gdl RCC CT MRI T 185 CT A B MRI A:T B:T Douglas red spot S ml RCC 186 A B mg CAUml S MRI A B 187 188 S mg Sampson JA. Intestinal adenomas of endometriosis

29

9 .,,, 3 () C k k C k C + C + C + + C 8 + C 9 + C k C + C + C + C 3 + C 4 + C 5 + + 45 + + + 5 + + 9 + 4 + 4 + 5 4 C k k k ( + ) 4 C k k ( k) 3 n( ) n n n ( ) n ( ) n 3 ( ) 3 3 3 n 4 ( ) 4 4 4 ( ) n n

200 30 984 1 1854 1713 1000 1008 ED ADL/QOL The European Working Group on Sarcopenia in Older People EWGSOP Asian Working Group for Sarcopenia AWGS D C Zhang, 2006 C Imamura, 2008 ATP Imamura, 2009 Imamura,

CE11122_h01-04B

CELEB LIFE TREATMENT MAGAZINE FOR CELEB MEMBERS 2 0 1 1 WINTER For the quality of healthy & sensual life CELEB LIFE TREATMENT MAGAZINE FOR CELEB MEMBERS 2 0 1 1 WINTER For the quality of healthy & sensual

P001-052.indd

Quality of Life 1 TEIJIN CSR Report 2014 2 TEIJIN CSR Report 2014 CONTENTS 3 5 9 15 21 23 25 26 28 37 38 41 42 29 30 34 35 36 43 44 45 49 50 51 52 http://www.teijin.co.jp/csr/ WEB 3 TEIJIN CSR Report 2014

1 1 (1) (2) 2 1 (1) (2) (3) (4) (5) 3 4 (1) (2) (3) (4)() (5) (6) (7) (8) 4 18 (1) (2) (3) 5 19 (1) (2) (3) (4) 6 () 21 (1) (2) <> Q&A () 23

1 1 (1) (2) 2 1 (1) (2) (3) (4) (5) 3 4 (1) (2) (3) (4)() (5) (6) (7) (8) 4 18 (1) (2) (3) 5 19 (1) (2) (3) (4) 6 () 21 (1) (2) Q&A () 23 1 ( 1 5 ) ( 4 ) (=) (1) () (2) () () (QOL) () () (1)(2) () 2

平成14年度（2002年度）事業計画（案）

142002 2001 2001 2001 2003 2004 2429 29 14-1 - 2001 2002 2003 2004 8 6 6 6 US 5 6 7 7 10 8 8 10 4 10 12 12 12 AG 1 1 1 3 3 3 8 7 7 910 89 8 FINA 6 10 FINA 8 8 7 7 3 910 89 8 FINA 10 LEN NORA 12 8 7 910

TMR

TMR 1 2 4 8 10 12 14 15 16 18 19 22 23 25 27 28 29 30 32 33 ha 1,153 4,549 25.3% 24 42 1,504 2.8% 26 423 6.2% (1) 11 222 5.0% (2) 4 859 0.5% 24 107 2,.514 4.3% 24 10,536 85,251 12.4% 5,119 58,790 8.7%

5 2 1 DDW2005 12 1 1 153

CT 357 3 4 152 5 2 1 DDW2005 12 1 1 153 22.5g2 100 5HT3 154 1999 CGRP Hepatogastroenterology52161-165,2005 2030 DPC 3.91.03.61.3 11.41.4 8.72.2p0.001 155 RCT 1 1997 20026 469237232 343164 179126 7353 156

267.indd

...-

...- ...- .,,.,,,,,.,,,,,,.,.,.,.,,,..,,,.,,,,,,,,,,,,, ,,..... .... ...... .....-...-... .- H.. ..... FD .-...... .....-... ......- .-....... .-.-...-......- .. ....,,...,,,,,.. .....- ,,,,,,,,,..-

21 1 503604705 MRI CT 1 3 MRIMRS 5 5 5 5 5 6 7 8 17 1 17 2 17 3 17 4 18 5 19 21 1 23 2 1 27 3 2 48 4 3 88 5 105 6 110 7 118 MRS MRS ATP 312CT 65 60 1 2 1 1 1 2 1 2 2 X CT MRS 3 36657269 MRIMRS 1.5TMRSymphony

名称未設定-2

ＥＲ７４‐５・抄録号／プログラム１１２６

SIRT17 JA ( 338 ) Common CavityCochlear nerve deficiency ( 339 ) video head impulse test vhit VEMP ( 340 ) P001 ( 341 ) P002 P003 P004 P005 P006 P007 P008 ( 342 ) P009 Square Drawing Test P010 P011 P012

<90CE90EC88E290D55F955C8E862E656336>

5 5 9 9 7 7 5 5 6 6 7 7 8 8 9 9 8 8 8 8 79 79 78 78 76 76 77 77 7 7 6 7 7 5 68 68 67 67 66 66 65 65 6 6 6 6 6 6 6 6 6 6 59 59 58 58 57 57 56 56 55 55 5 5 8 8 5 5 9 9 9 8 7 9 9 8 8 7 7 6 6 5 5 5 5 69 69

2 6

2 4 6 7 2 6 2 6 3 4 - c 5 G G G G G G d 6 c c 7 c 8 f d f d f d d f e f 5 b b d 5 c d d 9 d e d 0 0 5 c e cce 0 5 0 6 6 2 e 3 5 - e e e d b 4 bc d d d d dd ccdc c 5 d b c c e d 7 b f 6 6 s s s s s s s

30% 20% 24 (quality of life;qol) QOL '79 '89 '02 (Sleep apnea syndrome;sas) 1 SAS 2 5 P 5 P ( 1) (Physical) (Physiological) (Psychological) (Psychiatric) (Pharmacological) SAS 3 ( ) 5 ( ) 4 ( ) ( ) ( )

会派視察報告書　　清流会

1 (1) 2 6 H11 15 H17.4.23 (H15.11 ) 2 PAL 3 4 11 10 JA 10 11 1116 12 1214 12 12 1216 13 (JA ) 15 11 16 11 17 5 1188 4.8 3000 331 20 311 9000 2,740 74 6 5 1945 1960 1976 6 1 7 8 TeamZoo 12,201.1 6,149.1

発達障害_表01

2014p1_15

2014 00 1 2 2 4 4 5 7 9 9 11 14 37 38 40 54 16 17 18 23 24 24 29 56 56 57 60 1 2 3 4 5 1 2 3 4 5 6 6 7 8 9 10 11 12 13 14 資料編 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40

1 2 3 4 1 3 4 2 5 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 21 24 25 26 27 28 29 30 31 32 33 34 9 35 36 14 9 14 15 37 38 39 35 1 519 4 NPO 40 41 9 10 4 (9 Or10 ) PR 3 21 21 42 2 10 43 44 15

chapterc

PSCHG000.PS

FA X SA RS W H O DM AT ACLS TR BCG BCG GDP GDP JO A JC O A ATL W H O GNP OB g ICLS IC L S AED IC L S AED AED Dr. a ODA b c d d d d ddic d c VT VT VT VT VT VT VT VT VT VT VT VT c

JFA福島アカデミー2013.indd

26.1月号indd.indd

取扱説明書 [F-01D]

F-01D 12.7 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 a b 18 c d e 19 a b c d e f a b j k l g h i f m n o p a b c d e f g h i j k l m n o p a t y b X 20 a b a b a b c a b c 21 a b a b c a b c a b 22 23

健身計画2_04

2006 Konami Sports & Life 1 2 3 2006 Konami Sports & Life 4 5 6 2006 Konami Sports & Life 7 8 9 10 11 12 13 14 15 16 17 18 1 19 2 3 20 4 5 21 6 22 7 23 8 9 10 24 1 2 25 26 1 2 3 4 27 28 1 29 2 30 3 4

【HP用】26.12月号indd.indd

26.2月号indd.indd

No.639 334,300 44.7 840,700 885,000 669,700 705,000 631,700 665,000 6 1.40 12 1.55 460,000 2.95 415,000 395,000 172,200 172,200 140,100 140,100 6 1.225 0.645 12 1.375 0.645 2.600 1.290 12 10